Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Katinka, Albrecht"'
Autor:
Till Bärnighausen, Volker Harth, Johanna Callhoff, Hermann Brenner, Wolfgang Lieb, Annette Peters, Bernd Holleczek, Ilais Moreno Velásquez, Katinka Albrecht, Wolfgang Ahrens, Rudolf Kaaks, Andre Karch, Börge Schmidt, Johanna Mucke, Anja Strangfeld, Andreas Stang, Thomas Keil, Verena Katzke, Tamara Schikowski, Rafael Mikolajczyk, Carsten Oliver Schmidt, Michael Leitzmann, Klaus Berger, Tobias Pischon, Stefanie Castell, Markus Löffler, Kerstin Wirkner, Nadia Obi, Barbara Bohn, Stefan Willich, Janka Massag, Jana-Kristin Heise, Matthias Bernd Schulze, Sylvia Gastell, Kathrin Günther, Nina Ebert, Stefanie Jaskulski, Cara Övermöhle, Claudia Meinke-Franze, Beate Fischer, Lena Koch-Gallenkamp, Karin Greiser
Publikováno v:
RMD Open, Vol 10, Iss 4 (2024)
Objective To assess the presence of mental health disorders in persons with rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), systemic lupus erythematosus (SLE) and Sjögren’s disease (SjD) (all: inflammatory rheuma
Externí odkaz:
https://doaj.org/article/6123d97f22b9419aa8ffa735e1cebd31
Autor:
Florian Milatz, Katinka Albrecht, Kirsten Minden, Ursula Marschall, Jens Klotsche, Johanna Callhoff
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 22, Iss 1, Pp 1-8 (2024)
Abstract Background Studies on prevalence rates of mental comorbidities in patients with juvenile idiopathic arthritis (JIA) have reported varying results and provided limited information on related drugs. The purpose of this study was to determine t
Externí odkaz:
https://doaj.org/article/cc84f52dd4744c99b8a9852b96eca857
Autor:
Katinka Albrecht, Hans-Peter Tony, Anja Strangfeld, Joern Kekow, Martin Schäfer, Yvette Meissner, Silke Zinke
Publikováno v:
RMD Open, Vol 9, Iss 4 (2023)
Objective To estimate the effects of Janus kinase inhibitors (JAKi), tumour necrosis factor inhibitors (TNFi), other biologic(b) or conventional synthetic(cs) disease-modifying antirheumatic drugs (DMARDs) on the risk of major adverse cardiovascular
Externí odkaz:
https://doaj.org/article/a12b1332d02044629ece91e4965e6012
Autor:
Johanna Callhoff, Katinka Albrecht, Anja Strangfeld, Ursula Marschall, Anne Constanze Regierer
Publikováno v:
RMD Open, Vol 9, Iss 1 (2023)
Objective To assess polypharmacy in women and men with psoriatic arthritis (PsA).Methods From the German BARMER health insurance database, 11 984 persons with PsA and disease-modifying antirheumatic drug therapy in 2021 were included and compared wit
Externí odkaz:
https://doaj.org/article/1f668ef45918406fbb5d1f6932230585
Publikováno v:
RMD Open, Vol 9, Iss 1 (2023)
Objective To investigate prevalence, incidence and medication of interstitial lung disease (ILD) among German individuals with rheumatoid arthritis (RA).Methods Nationwide BARMER claims data from 2007 to 2020 were used. RA-ILD was identified by diagn
Externí odkaz:
https://doaj.org/article/27d1e80b62c24713a4d85af6ca89ce9c
Autor:
Angela Zink, Johanna Callhoff, Martin Aringer, Katinka Albrecht, Katja Thiele, Susanna Späthling-Mestekemper, Ulrich von Hinüber, Kirsten Karberg
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
ObjectiveTo analyse the performance of the rheumatoid arthritis impact of disease (RAID) score in patients with ankylosing spondylitis, polymyalgia rheumatica, systemic lupus erythematosus, primary Sjögren’s syndrome, idiopathic inflammatory myosi
Externí odkaz:
https://doaj.org/article/edc118518df34aac930ee89bbdeb69ca
Publikováno v:
Lupus Science and Medicine, Vol 8, Iss 1 (2021)
Externí odkaz:
https://doaj.org/article/6d12794e59234867ad0a1783cc92106a
Publikováno v:
RMD Open, Vol 6, Iss 3 (2020)
Objective To assess satisfaction with the effectiveness and tolerability of treatments in patients with rheumatoid arthritis (RA).Methods Patients from the RABBIT register, starting a biological (b) or targeted synthetic (ts) disease-modifying antirh
Externí odkaz:
https://doaj.org/article/38a981fe3944410283a3718f93bb8aa7
Publikováno v:
Pharmacoepidemiology and Drug Safety. 32:517-525
To evaluate different algorithms for the identification of rheumatoid arthritis (RA) in claims data using patient-reported diagnosis as reference.Within longitudinal data from a large German statutory health insurance, we selected a random sample of
Autor:
Katinka Albrecht, Jan Leipe
Publikováno v:
Zeitschrift für Rheumatologie. 81:492-500